We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

S-TARget Achieves In Vivo Proof of Concept for Its Allergy Vaccine SG100

News   Apr 08, 2013

 
S-TARget Achieves In Vivo Proof of Concept for Its Allergy Vaccine SG100
 
 
Advertisement
 

RELATED ARTICLES

Two Is Better Than One For Novel COVID-19 Mouse Model

News

Researchers have developed a new mouse model to study SARS-CoV-2 infection and disease and to accelerate testing of novel treatments and vaccines against the novel coronavirus.

READ MORE

Embryos Could Be Susceptible to Coronavirus, Study Suggests

News

Genes that are thought to play a role in how the SARS-CoV-2 virus infects our cells have been found to be active in embryos as early as during the second week of pregnancy, say scientists at the University of Cambridge and the California Institute of Technology. The researchers say this could mean embryos are susceptible to COVID-19 if the mother gets sick, potentially affecting the chances of a successful pregnancy.

READ MORE

Nose Study Sniffs Out the Origins of Parkinson's Disease

News

New research into the origins of Parkinson’s disease has identified a critical signaling molecule that may be key to the domino effect kicked off by nasal inflammation.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE